Picture supply: Getty Photos
For years, the Aviva (LSE: AV) share value couldn’t catch a break. Now it’s flying, up 23.76% within the final 12 months and 33.79% over 5 years.
That’s a fairly nifty return for a longtime FTSE 100 blue-chip working in a mature and aggressive sector. Particularly as my figures solely present share value development. Throw in Aviva’s ultra-high dividend, and the 12-month complete return is nearer to 30%. Over 5 years, buyers will probably be nearly 70% to the nice.
At the moment, Aviva shares include a trailing yield of 6.81%. That’s forecast to hit 7.25% in 2024 and seven.4% in 2025.
Can it proceed to beat its FTSE 100 rivals?
Right here’s my first quibble. Dividend cowl is skinny, at round 1.2. I want it to be nearer to 2 instances earnings. That raises questions over whether or not shareholder payouts are sustainable. However analysts seem to assume so, judging by these rising yield forecasts.
The board felt assured sufficient capable of hike the full-year 2023 dividend 7.7% to 33.4p per share. Aviva has now returned greater than £9bn in capital and dividends to shareholders over simply three years. And it lately launched a brand new £300m share buyback programme.
Making sufficient cash to develop dividends doesn’t seem like an issue. First-half earnings to 30 June jumped 58% to £654m, with working earnings rose 14% to £875m.
And as soon as once more, the board appeared comfy mountaineering the dividend, with the interim payout elevated by 7% to 11p.
Aviva is performing properly throughout two key markets – normal insurance coverage and insurance coverage, pension and retirement gross sales. It has a strong steadiness sheet, with a Solvency II cowl ratio of 205%, though it slipped by 2 share factors.
It additionally has a giant alternative in bulk annuity gross sales, the place it “secured excellent volumes of £5.5bn at strong margins” in 2023. Nevertheless, this can be a aggressive space, with Authorized & Normal Group, M&G and Simply Group simply a few of these eyeing the sector.
It’s beating rival blue-chips
Additional rate of interest cuts could also be a combined bag. It’s going to make in the present day’s whopping yield much more enticing, as financial savings charges and bond yields retreat, and increase funding sentiment typically. Nevertheless, I’m frightened that falling rates of interest might hit an annuity gross sales, which have loved a bump from in the present day’s increased charges. That would eat into revenues and sentiment.
As a rule, I’m cautious of shopping for shares on the again of a powerful run just like the one Aviva has simply loved. I’m questioning how a lot fuel it has left in its tank. A market downturn would hit the worth of its funding portfolio, hitting the corporate’s steadiness sheet and investor sentiment.
With the inventory buying and selling at a modest 13.81 instances earnings, just one factor is holding me again. I even have huge holdings in FTSE 100 rivals Authorized & Normal Group and M&G. They’ve been a bit garbage, frankly, falling 0.39% and rising 3.46 respectively over the past 12 months.
I again the flawed horses, no less than thus far, however as I mentioned, investing is cyclical. I want I’d purchased Aviva, however I’ve made my selection and can persist with L&G and M&G.